Literature DB >> 22193245

Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Bhushan J Toley1, Neil S Forbes.   

Abstract

Motile bacteria can overcome the penetration limitations of cancer chemotherapeutics because they can actively migrate into solid tumors. Although several genera of bacteria have been shown to accumulate preferentially in tumors, the spatiotemporal dynamics of bacterial tumor colonization and their dependence on bacterial motility are not clear. For effective tumor regression, bacteria must penetrate and distribute uniformly throughout tumors. To measure these dynamics, we used an in vitro model of continuously perfused tumor tissue to mimic the delivery and systemic clearance of Salmonella typhimurium strains SL1344 and VNP20009, and Escherichia coli strains K12 and DH5α. Tissues were treated for 1 hour with 10(5) or 10(7) CFU ml(-1) suspensions of each strain and the location and extent of bacterial accumulation were observed for 30 hours. Salmonella had 14.5 times greater average swimming speed than E. coli and colonized tissues at 100 times lower doses than E. coli. Bacterial motility strongly correlated (R(2) = 99.3%) with the extent of tissue accumulation. When inoculated at 10(5) CFU ml(-1), motile Salmonella formed colonies denser than 10(10) CFU/(g-tissue) and less motile E. coli showed no detectable colonization. Based on spatiotemporal profiles and a mathematical model of motility and growth, bacterial dispersion was found to be necessary for deep penetration into tissue. Bacterial colonization caused apoptosis in tumors and apoptosis levels correlated (R(2) = 98.6%) with colonization density. These results show that motility is critical for effective distribution of bacteria in tumors and is essential for designing cancer therapies that can overcome the barrier of limited tumor penetration. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Year:  2011        PMID: 22193245      PMCID: PMC4956405          DOI: 10.1039/c2ib00091a

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  49 in total

Review 1.  Use of preferentially replicating bacteria for the treatment of cancer.

Authors:  M Sznol; S L Lin; D Bermudes; L M Zheng; I King
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma.

Authors:  David M Heimann; Steven A Rosenberg
Journal:  J Immunother       Date:  2003 Mar-Apr       Impact factor: 4.456

3.  Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

Authors:  C Clairmont; K C Lee; J Pike; M Ittensohn; K B Low; J Pawelek; D Bermudes; S M Brecher; D Margitich; J Turnier; Z Li; X Luo; I King; L M Zheng
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

Review 4.  Ecological role of energy taxis in microorganisms.

Authors:  Gladys Alexandre; Suzanne Greer-Phillips; Igor B Zhulin
Journal:  FEMS Microbiol Rev       Date:  2004-02       Impact factor: 16.408

5.  Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility.

Authors:  Jochen Stritzker; Stephanie Weibel; Carolin Seubert; Andreas Götz; Achim Tresch; Nico van Rooijen; Tobias A Oelschlaeger; Philip J Hill; Ivaylo Gentschev; Aladar A Szalay
Journal:  Int J Med Microbiol       Date:  2010-05-23       Impact factor: 3.473

6.  Antitumor effect of Bifidobacterium infantis in mice.

Authors:  Y Kohwi; K Imai; Z Tamura; Y Hashimoto
Journal:  Gan       Date:  1978-10

7.  Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli.

Authors:  Jung-Joon Min; Hyun-Ju Kim; Jae Hyo Park; Sungmin Moon; Jae Ho Jeong; Yeoung-Jin Hong; Kyoung-Oh Cho; Jong Hee Nam; Nacksung Kim; Young-Kyu Park; Hee-Seung Bom; Joon Haeng Rhee; Hyon E Choy
Journal:  Mol Imaging Biol       Date:  2007-11-10       Impact factor: 3.488

8.  Containment of tumor-colonizing bacteria by host neutrophils.

Authors:  Kathrin Westphal; Sara Leschner; Jadwiga Jablonska; Holger Loessner; Siegfried Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

9.  Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.

Authors:  Markus Loeffler; Gaelle Le'Negrate; Maryla Krajewska; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

10.  Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.

Authors:  Chisa Nagakura; Katsuhiro Hayashi; Ming Zhao; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Michael Bouvet; Robert M Hoffman
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

View more
  35 in total

1.  Persistent enhancement of bacterial motility increases tumor penetration.

Authors:  Dana N Thornlow; Emily L Brackett; Jonathan M Gigas; Nele Van Dessel; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2015-09-04       Impact factor: 4.530

2.  Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses.

Authors:  Jan T Panteli; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2016-09-20       Impact factor: 4.530

Review 3.  Potent and tumor specific: arming bacteria with therapeutic proteins.

Authors:  Nele Van Dessel; Charles A Swofford; Neil S Forbes
Journal:  Ther Deliv       Date:  2015-03

4.  Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating.

Authors:  Miaomin Zhang; Neil S Forbes
Journal:  J Control Release       Date:  2014-12-15       Impact factor: 9.776

5.  Quorum-sensing Salmonella selectively trigger protein expression within tumors.

Authors:  Charles A Swofford; Nele Van Dessel; Neil S Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

6.  Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker.

Authors:  Jan T Panteli; Brittany A Forkus; Nele Van Dessel; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2015-04       Impact factor: 2.192

Review 7.  Salmonella-Mediated Cancer Therapy: Roles and Potential.

Authors:  Vu Hong Nguyen; Jung-Joon Min
Journal:  Nucl Med Mol Imaging       Date:  2016-06-01

8.  Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil.

Authors:  Bhushan J Toley; Zachary G Tropeano Lovatt; Josephine L Harrington; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2013-09       Impact factor: 2.192

9.  Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.

Authors:  Adam T St Jean; Charles A Swofford; Jan T Panteli; Zachary J Brentzel; Neil S Forbes
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

10.  Microfluidic Device to Quantify the Behavior of Therapeutic Bacteria in Three-Dimensional Tumor Tissue.

Authors:  Emily L Brackett; Charles A Swofford; Neil S Forbes
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.